MedTrace Logo

Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates

NCT03674307 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3306

Last updated 2024-05-13

No results posted yet for this study

Summary

The Canadian Australasian Randomized Trial of Screening Kidney Transplant Candidates for Coronary Artery Disease (CARSK) will test the hypothesis that eliminating the regular use of non-invasive screening tests for CAD AFTER waitlist activation is not inferior to regular (i.e., annual) screening for CAD during wait-listing for the prevention of Major Adverse Cardiac Events. Secondary analyses will assess the impact of screening on the rate of transplantation, and the relative cost-effectiveness of screening.

Conditions

Interventions

OTHER

No screening

No further screening for asymptomatic coronary artery disease after wait-list entry

OTHER

Regular Screening

Annual or second-yearly screening for asymptomatic coronary artery disease after wait-list entry

Sponsors & Collaborators

  • University of Sydney

    collaborator OTHER

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Jagbir Gill, MD · University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • United States
  • Canada
  • Germany
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03674307 on ClinicalTrials.gov